RhumbLine Advisers’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.6M | Sell |
|
|||||
|
2025
Q2 | $6.45M | Buy |
|
|||||
|
2025
Q1 | $6.84M | Buy |
|
|||||
|
2024
Q4 | $14.1M | Buy |
|
|||||
|
2024
Q3 | $18.8M | Buy |
|
|||||
|
2024
Q2 | $12M | Buy |
|
|||||
|
2024
Q1 | $10.1M | Buy |
|
|||||
|
2023
Q4 | $8.2M | Buy |
|
|||||
|
2023
Q3 | $6.64M | Buy |
|
|||||
|
2023
Q2 | $6.2M | Buy |
|
|||||
|
2023
Q1 | $3.57M | Buy |
|
|||||
|
2022
Q4 | $4.4M | Buy |
|
|||||
|
2022
Q3 | $1.64M | Buy |
|
|||||
|
2022
Q2 | $1.34M | Buy |
|
|||||
|
2022
Q1 | $1.23M | Buy |
|
|||||
|
2021
Q4 | $1.12M | Sell |
|
|||||
|
2021
Q3 | $1.2M | Buy |
|
|||||
|
2021
Q2 | $1.02M | Buy |
|
|||||
|
2021
Q1 | $565K | Buy |
|
|||||
|
2020
Q4 | $595K | Buy |
|
|||||
|
2020
Q3 | $1.01M | Buy |
|